About Trafficking protein particle complex subunit 4
Trafficking protein particle complex subunit 4 (TRAPPC4) is a protein
from Homo sapiens identified by UniProt accession
Q9Y296, 219 residues long.
MolForge cross-references it against 0 known binders and
51 disease associations.
Target properties
| Protein name | Trafficking protein particle complex subunit 4 |
| UniProt accession | Q9Y296 |
| Gene | TRAPPC4 |
| Organism | Homo sapiens |
| Length | 219 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (51)
Diseases linked to this target (Open Targets).
- neurodevelopmental disorder with epilepsy, spasticity, and brain atrophy · score 0.70
- Glycogen storage disease due to glucose-6-phosphatase deficiency · score 0.57
- Glycogen storage disease due to glucose-6-phosphatase deficiency type b · score 0.57
- glycogen storage disease Ib · score 0.52
- congenital disorder of glycosylation, type IIw · score 0.52
- genetic disorder · score 0.41
- complex neurodevelopmental disorder · score 0.37
- disorder of glycogen metabolism · score 0.34
- neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies · score 0.34
- congenital disorder of glycosylation · score 0.26
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9Y296-F1 | alphafold | PREDICTED | 90.61 | — |
Amino-acid sequence (219 residues)
MAIFSVYVVN KAGGLIYQLD SYAPRAEAEK TFSYPLDLLL KLHDERVLVA FGQRDGIRVG HAVLAINGMD VNGRYTADGK EVLEYLGNPA NYPVSIRFGR PRLTSNEKLM LASMFHSLFA IGSQLSPEQG SSGIEMLETD TFKLHCYQTL TGIKFVVLAD PRQAGIDSLL RKIYEIYSDF ALKNPFYSLE MPIRCELFDQ NLKLALEVAE KAGTFGPGS
Explore Trafficking protein particle complex subunit 4 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets